Haisco Pharmaceutical Group Co., Ltd
Customers
0
None disclosed
Suppliers
1
0 disclosed
Latest period
Mar 31, 2022
10-Q filed 2022-05-04
Suppliers 1
Companies that disclose Haisco Pharmaceutical Group Co., Ltd as a major customer, as a share of their own revenue. 0 active, 1 lapsed.
| Company | % of their revenue | Est. $ from Haisco Pharmaceutical Group Co., Ltd | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| AQST Aquestive Therapeutics, Inc. |
Named | — | 3M 2022-03-31 | — | Lapsed Last seen 2022-03-31 |
10-Q 2022-05-04 |
As of March 31, 2022, Indivior and Haisco Pharmaceutical Group Co., Ltd. ("Haisco") exceeded the 10% threshold for outstanding receivables and represented 43% and 34%, respectively, of outstanding receivables. | ||||||
Alerts are coming
Get an email when Haisco Pharmaceutical Group Co., Ltd's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.